Digg
Del.icio.us
Newsvine 
Facebook
StumbleuponMELBOURNE, Aug 19 (Reuters) - Shares in Australian biotherapies group CSL Ltd rose 3 percent after it beat market expectations with a 63 percent rise in full year profit and gave an upbeat forecast.
By 0003 GMT, CSL shares were at A$34.57, after an early peak of A$34.65, compared with 0.5 percent rise in the benchmark S&P/ASX 200 index .AXJO. ($1=1.210 Australian Dollar) (Reporting by Sonali Paul)
Corey Haim's possessions are auctioned off to pay for his funeral in Toronto. Fans are urged to donate as much as they can to Haim's mother, Judy...
After Chile's massive earthquake and potential Pacific Rim tsunami damage, relie...
Disable was brutally attacked by two teens in a railway station in Sydney.
© 2010 The Ibtimes Company. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
